EN
HI
Summary
As of 30 Aug, 2026, Ipca Laboratories stock price is ₹1950.3. During the trading session, the stock has moved between an intraday low of ₹1929.80 and an intraday high of ₹1977.30. Over the last 52 weeks, Ipca Laboratories has traded between ₹1251.60 and ₹1992.00.
The stock has recorded a trading volume of 2,76,397 shares, with a market capitalization of ₹253704218. Its Average Traded Price (ATP) is ₹1946.24, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 5 @ ₹1950.30.
Ipca Laboratories has an upper circuit limit of ₹2340.30 and a lower circuit limit of ₹1560.30. The total value traded stands at ₹53.79 CR, and the delivery percentage for the day is 54.22%.
The stock is currently traded with a market lot size of 1. Ipca Laboratories also offers a dividend yield of 0.31%.
Ipca Laboratories share price chart
Ipca Laboratories Share Key Metrics
Volume
2.76 L
Market Cap
49479.93 CR
LTQ@LTP
5@1950.30
ATP
1946.24
Var Margin
15.81 %
Circuit Range
1560.3-2340.3
Delivery %
54.22 %
Value
53.79 CR
ASM/GSM
No
Market Lot
1
Ipca Laboratories Fundamentals
P/E Ratio
37.79
P/B Ratio
5.83
Div. Yield
0.31
Sector P/E
69.1
Sector P/B
3.41
Sec. Div. Yield
0.51
Ipca Laboratories Resistance and Support
Pivot 1959.13
Resistance
First Resistance
1970.96
Second Resistance
1982.13
Third Resistance
1993.96
Support
First Support
1947.96
Second Support
1936.13
Third Support
1924.96
Ipca Laboratories Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Fri Aug 28 2026 | 1951 | 1950.3 | -0.48% | 1977.3 | 1929.8 |
| Thu Aug 27 2026 | 1954.8 | 1959.8 | 0.38% | 1970.3 | 1947.3 |
| Wed Aug 26 2026 | 1935.19 | 1952.4 | 1.24% | 1992 | 1935.09 |
Ipca Laboratories Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-13 | Quarterly Results |
| 2026-05-29 | Audited Results & Dividend |
| 2026-02-13 | Quarterly Results |
| 2025-11-13 | Quarterly Results |
| 2025-08-11 | Quarterly Results |
| 2025-05-29 | Audited Results & Final Dividend |
| 2025-02-13 | Quarterly Results |
| 2024-11-14 | Quarterly Results & Interim Dividend |
| 2024-09-30 | Others |
| 2024-08-13 | Quarterly Results |
Ipca Laboratories News
Ipca Laboratories Ltd - 524494 - Board Meeting Outcome for Standalone And Consolidated Unaudited Financial Results For Q1FY27
Ipca Laboratories' Q1 FY27 consolidated net profit increased 72% YoY to ₹401.89 crore, with revenue growing 21% YoY to ₹2788.10 crore. The board also approved the amalgamation of Krebs Biochemicals, effective April 1, 2026, subject to necessary consents.
Aug 13 2026 13:33:24
Ipca Laboratories Ltd - 524494 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Ipca Laboratories will conduct an earnings conference call on August 14, 2026, at 15:30 hrs IST. The call will discuss the company's Q1FY27 earnings and business update, following the results announcement on August 13, 2026.
Aug 06 2026 13:24:23
Ipca Laboratories Management
| Name | Position |
|---|---|
| Harish P Kamath | Corporate Counsel & Company Secretary, Compliance Officer |
| Premchand Godha | Chairman |
Ipca Laboratories Similar Stocks
Aster DM Quality Care Ltd.
748.40
-6.40 (0.85%)
Alkem Laboratories Ltd.
5355.00
35.00 (0.66%)
Abbott India Ltd.
26175.00
-175.00 (0.66%)
Anthem Biosciences Ltd.
900.10
-24.50 (2.65%)
Glaxosmithkline Pharmaceuticals Ltd.
3106.40
37.30 (1.22%)
Gland Pharma Ltd.
2888.00
14.50 (0.50%)
Ajanta Pharma Ltd.
3557.00
13.40 (0.38%)
Global Health Ltd.
1472.20
-36.70 (2.43%)
Ipca Laboratories FAQs
The Buying Price of Ipca Laboratories share is 1950.3 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Ipca Laboratories stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Ipca Laboratories, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Ipca Laboratories shares is 37.79. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Ipca Laboratories shares is 5.83. Useful to assess the stock's value relative to its book value.
To assess Ipca Laboratories’s valuation compare Sector P/E, P/B which are 69.1 & 3.41 with sector averages, along with growth rates and financial metrics.
The Market Cap of Ipca Laboratories is 49479.93 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Ipca Laboratories share price is 1992.00 & 1251.60. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Ipca Laboratories belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
